Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trialThomas L Holland, Robert C. Hyzy, Nicole Engen et al.|The Lancet Respiratory Medicine|2022Cited by 127
Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists WorkshopMichael O. Harhay, Alexandre Mebazaa, Jonathan D. Casey et al.|Intensive Care Medicine|2020Cited by 77